Replies to post #522626 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

thanks for sharing your opinion but experts disagree

have a good one gro

[meirluc]

Hygro, if 95% of the 331 patients had the mutant IDH type of GBM, there would have been about 314 patients that would have carried the mutant IDH GBM and only about 17 would have carried the wild type. That could be true in one in a million trials and here you are telling us that NWBO hit that jack pot. Everything about this trial seems to be extraordinary

[Roman516]

GBM patients would prefer treatment from NWBO as soon as possible months not year as approvals is expected by the end of the year or first quarter of 2023 not in 2024.

[Dr Bala]

The non-IDH-mutant is around 95%. Whatever you do, please don't go bankrupt.